Skip to main content
Integrity IndexIntegrity Index
← Companies
VXRT

Vaxart, Inc.

Data as of Oct 6, 2026
VXRT
CIK 72444Biological Products, (No Diagnostic Substances)
Reported federal lobbying
$270K
6 filings · latest Jul 20, 2026
Federal contracts since 2024
$9.3M
1 awards · latest Jan 24, 2024

Trades

7 reported trades in VXRT by 1 members of Congress since Feb 4, 2014: 0 purchases and 7 sales. Amounts are the ranges members report on periodic transaction reports.

Trades
7
Buys / sells
0 / 7
Members
1

Most recent

  • RMichael T. McCaulSale$50,001+Jan 6, 2016
  • RMichael T. McCaulSale$50,001+Jan 5, 2016
  • RMichael T. McCaulSale$15,001+Jul 3, 2014
  • RMichael T. McCaulSale$50,001+Jun 13, 2014
  • RMichael T. McCaulSale$50,001+Feb 6, 2014
  • RMichael T. McCaulSale$50,001+Feb 5, 2014
  • RMichael T. McCaulSale$15,001+Feb 4, 2014

Data: FEC (PAC contributions, Schedule A), Quiver Quantitative (congressional holdings, lobbying, contracts), Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to Vaxart, Inc. through its SEC registration (CIK 72444) and tickers VXRT.

As of: lobbying filings through Jul 20, 2026; contract actions through Jan 24, 2024. Snapshot rebuilt Oct 6, 2026.

Holdings values are estimates from disclosed ranges. PAC contributions cover the current and previous election cycle and count only gifts to sitting members' principal campaign committees, so leadership PACs and losing candidates are not included.